We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Metastasis

Neurovascular signaling for repair enhances brain metastasis

Stemness is responsible for onset and metastasis of colorectal cancer

Chemotherapy-induced metastasis: An unexpected foe?

Combined NOTCH/MAPK inhibition: A promising new anticancer approach

MAPK signaling pathway Novus Biologicals

By Yoskaly Lazo-Fernandez, PhD

Developmental regulator Daam2 promotes glial cell tumors by degrading Von Hippel-Lindau protein

Autophagy Inhibition in Cancer: Clinical Trials Update

Multifaceted Roles of Matrix Metalloproteinase-2 (MMP2) in Normal and Disease State

MMP2 is a 72 kDa enzymatic protein and it belongs to matrix metalloproteinases (MMPs), a heterogenous family of zinc/calcium-dependent TIMPs (tissue inhibitors of matrix metalloproteinases) regulated matrix-degrading endopeptidases which are classified into collagenases (MMP-1, -8, -13, -18), gelatinases (MMP-2, -9), stromelysins (MMP-3, -7, -10, -11), elastase (MMP-12), and membrane-type matrix metalloproteinases (MT-MMP-1 through -5) (1). MMP2 involves in extracellular matrix metabolism and cleaves type IV collagen along with degrading the already denatured collagens.

CD63: is it pro-metastatic or anti-metastatic?

CD63 is a type II membrane protein belonging to tetraspanin superfamily and it play key roles in the activation of several cellular signaling cascades along with acting as TIMP1 receptor. It is expressed by activated platelets, monocytes, macrophages, granulocytes, T /B cells, and different type of cancer cells. CD63 localizes to endosomes, lysosomes and on the cellular surfaces, and is often considered as a marker for late endosomes as well as for lysosomes.